期刊文献+

胆汁酸及其受体与中枢神经系统疾病 被引量:4

Bile Acids and Their Receptors are Associated with Central Nervous System Diseases
下载PDF
导出
摘要 胆汁酸不仅促进脂类吸收,还参与调节机体的糖脂代谢和能量平衡。胆汁酸受体在多种组织和细胞中表达,包括中枢神经元、小胶质细胞和星形胶质细胞,并具有抗炎和抗凋亡的作用。目前已发现,胆汁酸可以通过其受体直接或间接作用于大脑。胆汁酸及其受体除了在糖尿病、肥胖和肝胆疾病等代谢性疾病中发挥重要作用外还参与了一些其他疾病过程,如炎症导致的中枢神经系统疾病、肝性脑病和肌萎缩侧索硬化症等。然而,胆汁酸及其受体在中枢神经系统中的作用研究才刚刚起步,还有许多科学问题亟待探究。该文综述了胆汁酸的生物合成和调节、受体分类和特点、受体激动剂和信号转导以及在中枢神经系统疾病中的最新发现。 Bile acids not only promote lipid absorption,but also regulate the body’s glycolipid metabolism and energy balance.Bile acid receptors are expressed in a variety of tissues and cells,including central neurons,microglia,and astrocytes,and have anti-inflammatory and antiapoptotic effects.It has now been found that bile acids can act directly on the brain through their receptors.Bile acids and their receptors play an important role in metabolic diseases including diabetes,obesity,hepatobiliary diseases and other diseases,such as central nervous system diseases caused by inflammation,hepatic encephalopathy and amyotrophic lateral sclerosis.However,the study on the role of bile acids and their receptors in central nervous system has just started,and there are still many problems to be explored.This article reviews the biosynthesis and regulation of bile acids,receptor classification and characteristics,receptor agonists,signal transduction,and recent discoveries in central nervous system diseases.
作者 吴县 洪浩 WU Xian;HONG Hao(Department of Pharmacology,China Pharmaceutical University,Nanjing,210009,China)
出处 《神经药理学报》 2019年第1期23-30,共8页 Acta Neuropharmacologica
基金 国家自然科学基金面上项目(No.81573413,No.81273497,No.81773714)
关键词 胆汁酸 胆汁酸受体 代谢性疾病 中枢神经系统疾病 bile acids bile acid receptors metabolic diseases central nervous system
  • 相关文献

参考文献2

二级参考文献141

  • 1[93]Cariou B,van Harmelen K,Duran-Sandoval D,van Dijk TH,Grefhorst A,Abdelkarim M,Caron S,Torpier G,Fruchart JC,Gonzalez FJ,Kuipers F,Staels B.The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.J Biol Chem 2006; 281:11039-11049
  • 2[94]Eromm H,Eschler A,Tollner D,Canzler H,Schmidt FW.[In vivo dissolving of gall-stones:the effect of chenodeoxycholic acid.(author's transl)] Dtsch ivied Wochenschr 1975; 100:1619-1624
  • 3[95]Camarri E,Fici F,Marcolongo R.Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.Int J Clin Pharmacol Biopharm 1978; 16:523-526
  • 4[96]Carulli N,Ponz de Leon M,Podda M,Zuin M,Strata A,Frigerio G,Digrisolo A.Chenodeoxycholic acid and ursodeoxycholic acid effects in endogenous hypertriglyceridemias.A controlled double-blind trial.J Clin Pharmacol 1981; 21:436-442
  • 5[97]Crouse JR 3rd.Hypertriglyceridemia:a contraindication to the use of bile acid binding resins.Am J Med 1987; 83:243-248
  • 6[98]Beil U,Crouse JR,Einarsson K,Grundy SM.Effects of interruption of the enterohepatic circulation of bile acids on the transport of very low density-lipoprotein triglycerides.Metabolism 1982; 31:438-444
  • 7[99]Lambert G,Amar MJ,Guo G,Brewer HB Jr,Gonzalez FJ,Sinai CJ.The farnesoid X-receptor is an essential regulator of cholesterol homeostasis.J Biol Chem 2003; 278:2563-2570
  • 8[100]Watanabe M,Houten SM,Wang L,Moschetta A,Mangelsdorf DJ,Heyman RA,Moore DD,Auwerx J.Bile acids lower triglyceride levels via a pathway involving FXR,SHP,and SREBP-1c.J Clin Invest 2004; 113:1408-1418
  • 9[101]Repa JJ,Liang G,Ou J,Bashmakov Y,Lobaccaro JM,Shimomura I,Shan B,Brown MS,Goldstein JL,Mangelsdorf DJ.Regulation of mouse sterol regulatory elementbinding protein-1c gene (SREBP-1c) by oxysterol receptors,LXRalpha and LXRbeta.Genes Dev 2000; 14:2819-2830
  • 10[102]Horton JD,Goldstein JL,Brown MS.SREBPs:activators of the complete program of cholesterol and fatty acid synthesis in the liver.J Clin Invest 2002; 109:1125-1131

共引文献12

同被引文献50

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部